Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06807099 · ClinicalTrials.gov registry record
WRAP North America
A clinical trial of Venous Occlusion and Venous Stenosis, sponsored by Merit Medical Systems.
- Recruiting
- Registry status
- 250
- Enrollment target
- 12
- Study locations
NCT06807099 is a study of Venous Occlusion and Venous Stenosis that is actively recruiting participants, run by Merit Medical Systems. The registered enrollment target is 250 participants, above the 166-participant average among 4 other Venous Occlusion trials with a reported enrollment target (51% higher). The trial reports 12 study locations across 8 states.
The verdict
NCT06807099, a study of Venous Occlusion and Venous Stenosis, is actively recruiting participants, sponsored by Merit Medical Systems.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 12
- Study locations
Study Summary
The goal of this observational study is to investigate the safety and efficacy of the WRAPSODY CIE in a real-world North American population. Participants treated with the WRAPSODY CIE device in accordance with the device instructions for use will be followed in accordance with standard of care up to 3-years post-procedure.
Conditions Studied
Interventions
- DEVICE Merit WRAPSODY® Cell Impermeable Endoprosthesis (WRAPSODY CIE)
Study Locations (12)
South Carolina
- Medical University of South Carolina - Charleston
- Medical University of South Carolina - Orangeburg
- Spartanburg Medical System - Spartanburg
Texas
- Texas Research Institute - Fort Worth
- Humble Vascular Surgical Center - Humble
- San Antonio Kidney Disease Center - San Antonio
Alabama
- Trinity Research Group - Dothan
Florida
- Sarasota Memorial Research Institute - Sarasota
Kentucky
- University of Kentucky - Lexington
Tennessee
- Bluff City Vascular - Memphis
Virginia
- Sentara Vascular Specialists - Virginia Beach
Ontario
- University Health Network - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-07-31 |
| Est. Completion | 2030-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06807099
The ClinicalTrials.gov registry entry for NCT06807099 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 166-participant average among 4 other Venous Occlusion trials with a reported enrollment target (51% higher). The listed sponsor is Merit Medical Systems, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Venous Occlusion appearing as the primary indexed condition, and to 1 intervention - of which Merit WRAPSODY® Cell Impermeable Endoprosthesis (WRAPSODY CIE) is the first listed.
NCT06807099 reports 12 study locations spanning 8 distinct geographic areas - top geographies include South Carolina, Texas, Alabama.
Frequently Asked Questions
What is clinical trial NCT06807099 about?
NCT06807099 is a clinical study titled "WRAP North America". The goal of this observational study is to investigate the safety and efficacy of the WRAPSODY CIE in a real-world North American population. Participants treated with the WRAPSODY CIE device in accordance with the device instructions for use will be followed in accordance with standard of care up t...
What is the current status of trial NCT06807099?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-07-31. Estimated completion is 2030-07.
What conditions does trial NCT06807099 study?
This clinical trial studies the following conditions: Venous Occlusion, Venous Stenosis.
What interventions are being tested in trial NCT06807099?
The interventions under investigation include: Merit WRAPSODY® Cell Impermeable Endoprosthesis (WRAPSODY CIE) (DEVICE).
Who is sponsoring clinical trial NCT06807099?
This trial is sponsored by Merit Medical Systems, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06807099 being conducted?
This trial has 12 study locations across Alabama, Florida, Kentucky, South Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Occlusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
RECRUITING · NA
-
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
ACTIVE NOT RECRUITING · NA
-
The Merit WRAPSODY AV Access Efficacy Study (WAVE)
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Surfacer System Approach to Central Venous Access
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.